AAPL336.06+6.66 (+2.02%) ▲|ABBV263.55+0.26 (+0.10%) ▲|ABT99.64-1.31 (-1.30%) ▼|ACN183.20+6.08 (+3.43%) ▲|ADBE239.02+5.85 (+2.51%) ▲|AMAT510.62-1.39 (-0.27%) ▼|AMD605.90-1.67 (-0.27%) ▼|AMGN423.73+0.09 (+0.02%) ▲|AMT164.69-0.87 (-0.53%) ▼|AMZN251.17+4.50 (+1.82%) ▲|AVGO353.41-1.69 (-0.48%) ▼|AXP305.25-0.15 (-0.05%) ▼|BA186.76-0.93 (-0.49%) ▼|BAC54.53-0.43 (-0.78%) ▼|BKNG162.88+0.54 (+0.33%) ▲|BLK1,064.86-3.09 (-0.29%) ▼|BMY62.98+0.12 (+0.19%) ▲|BNY145.34-1.65 (-1.12%) ▼|BRK-B501.04-1.31 (-0.26%) ▼|C129.72-1.08 (-0.83%) ▼|CAT819.79-6.85 (-0.83%) ▼|CL86.32-0.14 (-0.16%) ▼|CMCSA21.85+0.25 (+1.13%) ▲|COF193.62-2.85 (-1.45%) ▼|COP126.31+0.87 (+0.69%) ▲|COST918.75-5.84 (-0.63%) ▼|CRM229.34+4.03 (+1.79%) ▲|CSCO107.94+1.00 (+0.94%) ▲|CVS86.13-0.97 (-1.11%) ▼|CVX206.77+2.39 (+1.17%) ▲|DE672.96-5.92 (-0.87%) ▼|DHR223.44-2.27 (-1.01%) ▼|DIS105.46+0.05 (+0.05%) ▲|DUK114.40+0.19 (+0.17%) ▲|EMR156.55-0.70 (-0.44%) ▼|FDX285.71-1.77 (-0.61%) ▼|GD332.57+0.23 (+0.07%) ▲|GE314.48-3.41 (-1.07%) ▼|GEV957.48-5.02 (-0.52%) ▼|GILD150.44-0.85 (-0.56%) ▼|GM77.26-3.21 (-3.99%) ▼|GOOG346.71+9.39 (+2.78%) ▲|GOOGL350.06+9.14 (+2.68%) ▲|GS904.40-11.84 (-1.29%) ▼|HD285.31-2.73 (-0.95%) ▼|HON210.86+0.73 (+0.35%) ▲|IBM219.61-0.38 (-0.17%) ▼|INTC119.49+3.56 (+3.07%) ▲|INTU273.37+5.34 (+1.99%) ▲|ISRG409.01-3.17 (-0.77%) ▼|JNJ267.13-0.45 (-0.17%) ▼|JPM332.49-2.49 (-0.74%) ▼|KO86.53-0.32 (-0.36%) ▼|LIN479.64+6.27 (+1.32%) ▲|LLY1,176.31-8.32 (-0.70%) ▼|LMT510.06-2.16 (-0.42%) ▼|LOW185.49-1.78 (-0.95%) ▼|LRCX326.83+2.97 (+0.92%) ▲|MA556.39-7.19 (-1.28%) ▼|MCD232.20-1.79 (-0.76%) ▼|MDLZ58.37-0.44 (-0.74%) ▼|MDT87.02-0.07 (-0.08%) ▼|META734.35-4.44 (-0.60%) ▼|MMM166.12-2.37 (-1.41%) ▼|MO67.71-1.01 (-1.48%) ▼|MRK146.76-2.53 (-1.69%) ▼|MS189.32-3.44 (-1.78%) ▼|MSFT518.72+9.76 (+1.92%) ▲|MU1,068.81+3.73 (+0.35%) ▲|NEE76.19+0.30 (+0.39%) ▲|NFLX69.87-0.44 (-0.62%) ▼|NKE35.41-0.44 (-1.21%) ▼|NOW134.09+4.15 (+3.19%) ▲|NVDA230.29+3.08 (+1.35%) ▲|ORCL137.63-0.16 (-0.11%) ▼|PEP127.68-1.02 (-0.79%) ▼|PFE28.85+0.13 (+0.45%) ▲|PG146.71-1.61 (-1.09%) ▼|PLTR188.57+1.60 (+0.86%) ▲|PM192.49-1.41 (-0.73%) ▼|QCOM184.13+0.03 (+0.02%) ▲|RTX186.48-0.47 (-0.25%) ▼|SBUX95.09-0.34 (-0.36%) ▼|SCHW98.38-0.73 (-0.73%) ▼|SO83.45-0.01 (-0.01%) ▼|SPG201.92-2.37 (-1.16%) ▼|T24.53+0.05 (+0.21%) ▲|TMO682.06+2.45 (+0.36%) ▲|TMUS162.81-0.17 (-0.10%) ▼|TSLA353.67+0.83 (+0.24%) ▲|TXN282.08+0.39 (+0.14%) ▲|UBER68.85-0.51 (-0.74%) ▼|UNH369.25-5.69 (-1.52%) ▼|UNP274.27+0.12 (+0.04%) ▲|UPS93.84-0.09 (-0.10%) ▼|USB57.79+0.19 (+0.33%) ▲|V361.50-4.38 (-1.20%) ▼|VZ45.96-0.02 (-0.05%) ▼|WFC80.15-0.34 (-0.42%) ▼|WMT105.26-1.55 (-1.45%) ▼|XOM164.30+2.95 (+1.83%) ▲|AAPL336.06+6.66 (+2.02%) ▲|ABBV263.55+0.26 (+0.10%) ▲|ABT99.64-1.31 (-1.30%) ▼|ACN183.20+6.08 (+3.43%) ▲|ADBE239.02+5.85 (+2.51%) ▲|AMAT510.62-1.39 (-0.27%) ▼|AMD605.90-1.67 (-0.27%) ▼|AMGN423.73+0.09 (+0.02%) ▲|AMT164.69-0.87 (-0.53%) ▼|AMZN251.17+4.50 (+1.82%) ▲|AVGO353.41-1.69 (-0.48%) ▼|AXP305.25-0.15 (-0.05%) ▼|BA186.76-0.93 (-0.49%) ▼|BAC54.53-0.43 (-0.78%) ▼|BKNG162.88+0.54 (+0.33%) ▲|BLK1,064.86-3.09 (-0.29%) ▼|BMY62.98+0.12 (+0.19%) ▲|BNY145.34-1.65 (-1.12%) ▼|BRK-B501.04-1.31 (-0.26%) ▼|C129.72-1.08 (-0.83%) ▼|CAT819.79-6.85 (-0.83%) ▼|CL86.32-0.14 (-0.16%) ▼|CMCSA21.85+0.25 (+1.13%) ▲|COF193.62-2.85 (-1.45%) ▼|COP126.31+0.87 (+0.69%) ▲|COST918.75-5.84 (-0.63%) ▼|CRM229.34+4.03 (+1.79%) ▲|CSCO107.94+1.00 (+0.94%) ▲|CVS86.13-0.97 (-1.11%) ▼|CVX206.77+2.39 (+1.17%) ▲|DE672.96-5.92 (-0.87%) ▼|DHR223.44-2.27 (-1.01%) ▼|DIS105.46+0.05 (+0.05%) ▲|DUK114.40+0.19 (+0.17%) ▲|EMR156.55-0.70 (-0.44%) ▼|FDX285.71-1.77 (-0.61%) ▼|GD332.57+0.23 (+0.07%) ▲|GE314.48-3.41 (-1.07%) ▼|GEV957.48-5.02 (-0.52%) ▼|GILD150.44-0.85 (-0.56%) ▼|GM77.26-3.21 (-3.99%) ▼|GOOG346.71+9.39 (+2.78%) ▲|GOOGL350.06+9.14 (+2.68%) ▲|GS904.40-11.84 (-1.29%) ▼|HD285.31-2.73 (-0.95%) ▼|HON210.86+0.73 (+0.35%) ▲|IBM219.61-0.38 (-0.17%) ▼|INTC119.49+3.56 (+3.07%) ▲|INTU273.37+5.34 (+1.99%) ▲|ISRG409.01-3.17 (-0.77%) ▼|JNJ267.13-0.45 (-0.17%) ▼|JPM332.49-2.49 (-0.74%) ▼|KO86.53-0.32 (-0.36%) ▼|LIN479.64+6.27 (+1.32%) ▲|LLY1,176.31-8.32 (-0.70%) ▼|LMT510.06-2.16 (-0.42%) ▼|LOW185.49-1.78 (-0.95%) ▼|LRCX326.83+2.97 (+0.92%) ▲|MA556.39-7.19 (-1.28%) ▼|MCD232.20-1.79 (-0.76%) ▼|MDLZ58.37-0.44 (-0.74%) ▼|MDT87.02-0.07 (-0.08%) ▼|META734.35-4.44 (-0.60%) ▼|MMM166.12-2.37 (-1.41%) ▼|MO67.71-1.01 (-1.48%) ▼|MRK146.76-2.53 (-1.69%) ▼|MS189.32-3.44 (-1.78%) ▼|MSFT518.72+9.76 (+1.92%) ▲|MU1,068.81+3.73 (+0.35%) ▲|NEE76.19+0.30 (+0.39%) ▲|NFLX69.87-0.44 (-0.62%) ▼|NKE35.41-0.44 (-1.21%) ▼|NOW134.09+4.15 (+3.19%) ▲|NVDA230.29+3.08 (+1.35%) ▲|ORCL137.63-0.16 (-0.11%) ▼|PEP127.68-1.02 (-0.79%) ▼|PFE28.85+0.13 (+0.45%) ▲|PG146.71-1.61 (-1.09%) ▼|PLTR188.57+1.60 (+0.86%) ▲|PM192.49-1.41 (-0.73%) ▼|QCOM184.13+0.03 (+0.02%) ▲|RTX186.48-0.47 (-0.25%) ▼|SBUX95.09-0.34 (-0.36%) ▼|SCHW98.38-0.73 (-0.73%) ▼|SO83.45-0.01 (-0.01%) ▼|SPG201.92-2.37 (-1.16%) ▼|T24.53+0.05 (+0.21%) ▲|TMO682.06+2.45 (+0.36%) ▲|TMUS162.81-0.17 (-0.10%) ▼|TSLA353.67+0.83 (+0.24%) ▲|TXN282.08+0.39 (+0.14%) ▲|UBER68.85-0.51 (-0.74%) ▼|UNH369.25-5.69 (-1.52%) ▼|UNP274.27+0.12 (+0.04%) ▲|UPS93.84-0.09 (-0.10%) ▼|USB57.79+0.19 (+0.33%) ▲|V361.50-4.38 (-1.20%) ▼|VZ45.96-0.02 (-0.05%) ▼|WFC80.15-0.34 (-0.42%) ▼|WMT105.26-1.55 (-1.45%) ▼|XOM164.30+2.95 (+1.83%) ▲|
23.7 C
New York
Wednesday, September 30, 2026

Tag: 1

newssourceFORcompanyinformationcontent1releasesmarket

HealthRX Expands Telehealth Website Experience to Include GLP-1 Weight Loss Solutions, Prescription Access, and 24/7 Wellness Support

HealthRX enhances online platform to offer doctor-prescribed GLP-1 medications like Ozempic® and Zepbound® for adults seeking virtual weight loss support, prescription access, and 24/7 telehealth care 
HealthRX enhances online platform to offer doctor-prescribed GLP-1 medications like Ozempic® and Zepbound® for adults seeking virtual weight loss support, prescription access, and 24/7 telehealth care

Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025

MELBOURNE, Australia and INDIANAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces five abstract presentations and two satellite symposia featuring its developmental theranostic programs and commercial products at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025 Annual Meeting being held in New Orleans, Louisiana (U.S.) from June 21 – 24.

/C O R R E C T I O N — 50 Best/

In the news release, MAIDO, LIMA, IS NAMED NO.1 IN THE LIST OF THE WORLD'S 50 BEST RESTAURANTS 2025, issued June 19, 2025 by...

FinVolution Group Announces Proposed Offering of US$130 Million Convertible Senior Notes

SHANGHAI, June 19, 2025 /PRNewswire/ -- FinVolution Group ("FinVolution" or the "Company") (NYSE: FINV), a leading fintech platform in China, Indonesia and the Philippines,...

Shipsy to Drive Rapid Expansion in Australia, Establishes Regional Headquarters in Sydney to Support Growing Client Base

SYDNEY, June 20, 2025 /PRNewswire/ -- Shipsy, a Gartner-recognized global leader in AI-powered SaaS-based logistics management platform provider, recently announced its plans to aggressively...

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting of inducement awards to one new non-executive employee as described below. In accordance with NASDAQ Listing Rule 5635(c)(4), these awards were approved by Neuronetics’ Compensation Committee and made as a material inducement to their respective employment with the Company. In all cases, vesting is subject to the recipient’s continued service with the Company through the applicable vesting date, and the awards are subject to the terms of the Company’s 2020 Inducement Incentive Plan.

NORTHCLIFF ANNOUNCES NON-BROKERED PRIVATE PLACEMENT FINANCING

VANCOUVER, BC, June 19, 2025 /CNW/ - Northcliff Resources Ltd. ("Northcliff" or the "Company") (TSX: NCF) announces that it has arranged a non-brokered private...

National Bank of Canada Announces NVCC Subordinated Notes Offering

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./ MONTREAL, June 19, 2025 /CNW/ - National Bank of Canada...

ROSEN, LEADING INVESTOR COUNSEL, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FTRE

NEW YORK, June 19, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fortrea Holdings, Inc. (NASDAQ: FTRE) between July 3, 2023 and February 28, 2025, both dates inclusive (the “Class Period”), of the important August 1, 2025 lead plaintiff deadline.

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKT

NEW YORK, June 19, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between February 27, 2025 and May 26, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 11, 2025.

HER2-low Cancers Market Set to Register Immense Growth at a CAGR of 9.4% During the Study Period (2020-2034) | DelveInsight

The future of the HER2-low cancer treatment market is poised for significant transformation, driven by the approval of ENHERTU and the advancement of other...

Costa Rica Strengthens Its Position as a Regional Hub for the Audiovisual Industry with New Regional Market

Costa Rica Media Market will take place June 24–25 in San José, with over 500 business meetings and participation from buyers, producers, and experts...

Delta-like Ligand 3 Targeted Therapies Market is Predicted to Heat Up During the Forecast Period (2025-2034) Across 7MM Owing to a Robust Pipeline |...

The delta-like ligand 3 targeted therapies market is witnessing significant growth, driven by the rising incidence of small cell lung cancer (SCLC) and neuroendocrine...

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV

NEW YORK, June 19, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTags1

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers